Page last updated: 2024-11-01

ofloxacin and Arterial Occlusive Diseases

ofloxacin has been researched along with Arterial Occlusive Diseases in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Müller-Bühl, U1
Diehm, C1
Gutzler, F1

Other Studies

1 other study available for ofloxacin and Arterial Occlusive Diseases

ArticleYear
Tissue concentrations of ofloxacin in necrotic lesions in patients with peripheral vascular disease and in diabetics.
    Infection, 1986, Volume: 14 Suppl 4

    Topics: Aged; Anti-Infective Agents; Arterial Occlusive Diseases; Bacterial Infections; Diabetic Angiopathie

1986